Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Optimizing these processes involves fine-tuning various parameters, including cell line selection, media formulation, and bioreactor settings. A key goal is to increase antibody yield while reducing production expense